Tegafur
DB09256
Approved Indication
Indicated for the treatment of cancer usually in combination with other biochemically modulating drugs.
0
Targets
0
Resistance Mutations
3
References
3D Structure
No structure available
No co-crystal structure available
Protein Targets
Mechanism of Action
After administration into the body, tegafur is converted into the active antineoplastic metabolite, 5-fluorouracil (5-FU)
Details
DrugBank ID
DB09256 ↗
Approval Date
—
Molecular Weight
200.169 g/mol
Drug Class
Other
ATC Codes
L01BC53, L01BC03
Synonyms
—
PubChem
CID: 5386 ↗
ChEMBL
CHEMBL20883 ↗
SMILES
FC1=CN(C2CCCO2)C(=O)NC1=O
ADMET Profile
Computing properties…
Drug References (DrugBank)